Genky DrugStores Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/10/01Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥7 | -50.0% |
| 2025 | ¥13 | 0.0% |
| 2024 | ¥13 | +4.0% |
| 2023 | ¥13 | 0.0% |
| 2022 | ¥13 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥154,639M | ¥169,059M | ¥184,860M | ¥200,786M |
| Gross Profit | ¥30,954M | ¥34,553M | ¥37,620M | ¥40,889M |
| Operating Income | ¥5,675M | ¥6,709M | ¥9,015M | ¥9,658M |
| Pretax Income | ¥6,142M | ¥6,774M | ¥8,906M | ¥10,118M |
| Net Income | ¥4,420M | ¥4,764M | ¥6,324M | ¥7,066M |
| EPS | ¥145.44 | ¥156.79 | ¥207.94 | ¥232.04 |
| Operating Margin | 3.67% | 3.97% | 4.88% | 4.81% |
| Balance Sheet | ||||
| Total Assets | ¥97,118M | ¥105,912M | ¥113,939M | ¥127,326M |
| Total Equity | ¥36,232M | ¥40,680M | ¥46,679M | ¥53,427M |
| Total Liabilities | ¥60,886M | ¥65,232M | ¥67,260M | ¥73,899M |
| Cash | ¥5,438M | ¥5,329M | ¥5,896M | ¥6,221M |
| Interest-bearing Debt | ¥30,959M | ¥32,354M | ¥30,648M | ¥34,374M |
| Equity Ratio | 37.31% | 38.41% | 40.97% | 41.96% |
| D/E Ratio | 0.85 | 0.80 | 0.66 | 0.64 |
| Cash Flow | ||||
| Operating CF | ¥6,076M | ¥8,773M | ¥13,256M | ¥12,597M |
| Investing CF | -¥10,588M | -¥9,736M | -¥10,631M | -¥15,618M |
| Financing CF | ¥2,037M | ¥854M | -¥2,058M | ¥3,346M |
| Free CF | -¥4,430M | -¥1,155M | ¥2,815M | -¥2,510M |
| Efficiency | ||||
| ROE | 12.20% | 11.71% | 13.55% | 13.23% |
| ROA | 4.55% | 4.50% | 5.55% | 5.55% |
Latest IR Information
-
Monthly Sales Trend for 2025–2026 (Flash Report for September 2026 Monthly Results)
Year-over-year monthly comparisons of net sales, existing-store sales, customer traffic and spending per customer are presented, disclosing monthly trends for fiscal 2026 and new store plans (around nine additional or renovated stores). Foreign exchange impact is unknown. Full-year outlook for...
Read more -
Partial Change to the Notice Regarding Issuance of Stock Options (Stock Acquisition Rights)
Partial change to stock option allotment recipients. Total remains 1,000 units, target shares remain 100,000. Number of recipients increased (204 to 211) without changing the total allotment. Allotment date: September 30.
Read more -
Notice of Issuance of Stock Options (Stock Acquisition Rights)
Grant of 100,000 shares worth of stock options to 204 directors within the company and directors/employees of subsidiaries. Exercise period: October 1, 2028 to September 30, 2033. Total number of grant units: 1,000, with 100 shares per unit.
Read more -
2026/8/31 Monthly Financial Results (August Monthly Business Briefing for the 2027 Fiscal Year ending June)
Presents monthly data that underpins the trajectory of sales and store performance, along with assumptions for next term. Includes trends in new store openings, number of renovated stores, total store count, and cumulative mid-period indicators. Note that monthly figures are...
Read more -
Notice on Granted Stock Options (Stock Acquisition Rights)
The board resolved to grant stock acquisition rights under particularly favorable terms to internal directors, employees, and directors/employees of subsidiaries. The total grant cap is 1,500 rights, with 100 shares per right, and the issuance date is assumed to be...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥5,100
Rating Score: 1.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Genky DrugStores Finalizes New Equity-Based Stock Option Plan for Executives and Staff - TipRanks ↗
Genky DrugStores Expands Stock Option Eligibility Without Increasing Issuance - TipRanks ↗
Company Information
About
Genky DrugStores Co., Ltd. engages in the management and operation of food and drug chain stores in Japan. The company retails pharmaceuticals, cosmetics, miscellaneous goods, food, and other products. It also engages in food manufacturing, store development, and logistics business. Genky DrugStores Co., Ltd. was founded in 1988 and is headquartered in Sakai, Japan.
